Selective expression of CD44 cell-adhesion molecule in thyroid papillary carcinoma fine-needle aspirates

Diagnostic Cytopathology

Volumn 14, Issue 4, 1996, Pages 287-291

  Ross, Jeffrey S ^a,b   Del Rosario, Arthur D ^a   Sanderson, Barbara ^a   Bui, Hai X ^a  

^a STRATTON VA MEDICAL CENTER   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

CD44; Fine needle aspiration biopsy; Papillary carcinoma; Thyroid

Indexed keywords

CELL ADHESION MOLECULE; HERMES ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ASPIRATION BIOPSY; CANCER CYTODIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROGNOSIS; THYROID PAPILLARY CARCINOMA;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD44; BIOPSY, NEEDLE; CARCINOMA, PAPILLARY; EVALUATION STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 0029977731     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199605)14:4<287::AID-DC2>3.0.CO;2-D     Document Type: Article

References (39)

1. Bisi H, Asato de Camargo A, Longatto Filho A. Role of fine-needle aspiration cytology in the management of thyroid nodules: review of experience with 1,925 cases Diagn Cytopathol 1992;8:504-510.
2. LaRosa GL, Belfiore A, Giuffrida D, et al. Evaluation of the fine needle aspiration biopsy in the preoperative selection of cold thyroid nodules. Cancer 1991;67:2137-2141.
3. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993;328:553-559.
4. LiVolsi VA. Papillary neoplasms of the thyroid. Pathologic and prognostic features. Am J Clin Pathol 1992;97:426-434.
5. Matsuda M, Nagumo S, Koyama H, Wada A. Occult thyroid cancer discovered by fine-needle aspiration cytology of cervical lymph node: a report of three cases. Diagn Cytopathol 1991;7:299-303.
6. Scopa GD, Melachrinou M, Saradopoulou C, Merino MJ. The significance of the grooved nucleus in thyroid lesions. Mod Pathol 1993;6:691-694.
7. Akhtar M, Ali MA, Huq M, Bakry M. Fine-needle aspiration biopsy of papillary thyroid carcinoma: cytologic, histologic, and ultrastructural correlations. Diagn Cytopathol 1991;7:373-379.
8. Shurbaji MS, Gupta PK, Frost JK. Nuclear grooves: a useful criterion in the cytopathologic diagnosis of papillary thyroid carcinoma. Diagn Cytopathol 1988;4:91-94.
9. Chan JKC, Saw D. The grooved nucleus A useful diagnostic criterion of papillary carcinoma of the thyroid. Am J Surg Pathol 1986; 10:672-679.
10. Miller TR, Bottles K, Holly EA, Friend NF, Abele JAS. A step-wise logistic regression analysis of papillary carcinoma of the thyroid. Acta Cytol 1986;30:285-293
11. Gould E, Watzak L, Chamizo W, Albores-Saavedra J. Nuclear grooves in cytologic preparations. A study of the utility of this feature in the diagnosis of papillary carcinoma. Acta Cytol 1989;33: 16-20.
12. Harach HR, Zusman SB. Cytologic findings in the follicular variant of papillary carcinoma of the thyroid. Acta Cytol 1992;36:142-146.
13. Fiorella RM, Isley W, Miller LK, Kragel PJ. Multinodular goiter of the thyroid mimicking malignancy: diagnostic pitfalls in fine-needle aspiration biopsy. Diagn Cytopathol 1993;9:351-357.
14. Caraway NP, Sneige N, Samaan NA. Diagnostic pitfalls in thyroid fine-needle aspiration: a review of 394 cases. Diagn Cytopathol 1993; 9:345-350.
15. Harach HR, Zusman SB, Day BS. Nodular goiter: a histo-cytological study with some emphasis on pitfalls of fine-needle aspiration cytology. Diagn Cytopathol 1992;8.409-419.
16. Kaur A, Jayaram G. Thyroid tumors: cytomorphology of papillary carcinoma. Diagn Cytopathol 1991;7:462-468.
17. Aratake Y, Kotani T, Tamura K, et al. Dipetidyl aminopeptidase IV staining of cytological preparations to distinguish benign from malignant thyroid diseases. Am J Clin Pathol 1991;96:306-310.
18. Ghali VS, Jiminez EJS, Garcia RJ. Distribution of leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas. Hum Pathol 1992;23:21-25.
19. DeMicco C, Ruf J, Chrestian M, Gros N, Henry J, Carayon P. Immunohistochemical study of thyroid peroxidase in normal, hyperplastic, and neoplastic human thyroid tissues. Cancer 1991;67: 3036-3041.
20. Campo E, Merino MJ, Liotta L, Neumann R, Stetler-Stevenson W. Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue. Hum Pathol 1992,23:1395-1401.
21. Akslen LA. Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer 1993;72:2680-2685.
22. Schindler A, ven Melle G, Evequoz B, Scazziga B. Prognostic factors m papillary carcinomas of the thyroid. Cancer 1991;68: 324-330.
23. Van Hoeven KH, Menedez-Botet CJ, Strong EW, Huvos AG. Estrogen and progesterone receptor content m human thyroid disease. Am J Clin Pathol 1993;99:175-181.
24. Yamamoto Y, Izumi K, Otsuka H. An immunohistochemical study of epithelial membrane antigen, cytokeratin, and vimentin in papillary thyroid carcinoma. Recognition of lethal and favorable prognostic types. Cancer 1992;70:2326-2333.
25. Backdahl M, Cohn K, Auer G, et al. Comparison of nuclear DNA content in primary and metastatic papillary thyroid carcinoma. Cancer Res 1985,45:2890-2894.
26. Ambros RA, Trost RC, Campbell AY, Lambert C. Prognostic value of morphometry in papillary thyroid carcinoma. Hum Pathol 1989; 20:215-218.
27. Hostetter AI, Hrafnkelsson J, Wingren SOW, Enestrom S, Nordenskjold B. A comparative study of DNA cytometry methods for benign and malignant thyroid tissue. Am J Clin Pathol 1988;89: 760-763.
28. Kashyap V, Kaushik N, Bhambhani S, Das DK, Luthra UK. Supportive role of image analysis and DNA ploidy pattern in the diagnosis of thyroid tumors. Diagn Cytopathol 1992;8:228-230.
29. Salmon I, Gasperin P, Pasteels J, Heimann R, Kiss R. Relationship between histopathologic typing and morphonuclear assessments of 238 thyroid lesions. Digital cell analysis performed on Feulgen-stained nuclei from formalin-fixed paraffin-embedded materials. Am J Clin Pathol 1992;97:776-786.
30. Zetter BR. Adhesion molecules m tumor metastasis. Semin Cancer Biol 1993;4:219-229.
31. Albelda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 1993;68:4-17.
32. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992;340: 1053-1058.
33. Lesley J, Hyman R, Kincade PW. CD44 and its interaction extracellular matrix. Adv Immunol 1993;54:271-335.
34. Haynes BF, Telen MJ, Hale LP, Denning SM. CD44-A molecule involved in leukocyte adherence and T-cell activation. Immunol Today 1989;10:424-428.
35. Birch M, Mitchell S, Hart IR. Isolation and characterization of human melanoma cell variance expressing high and low levels of CD44. Cancer Res 1991;51:6660-6667.
36. Stamenkovic J, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991;10: 343-348.
37. Gunthert U, Hofmann M, Rudey W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
38. Arch R, Wirth K, Hofmann M, et al. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992;257:682-685.
39. Del Rosario, Bui HX, Wu AS, et al. CD44 and E-cadherin (EC) expression in transitional cell carcinoma of the urinary bladder (UB-TCC). Lab Invest 1994;70:73a.